Outset Medical Inc(OM) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -4.1 | Insider Own | 5.9% | Shs Outstand | 18.8M | Perf Week | -1.71% |
| Market Cap | 0.08B | Forward P/E | - | EPS next Y | 25.62% | Insider Trans | 23.25% | Shs Float | 17.7M | Perf Month | 7.47% |
| Enterprise Value | 0.03B | PEG | - | EPS next Q | -0.69 | Inst Own | 75.22% | Short Float | 5.27% | Perf Quarter | -19.24% |
| Income | -0.07B | P/S | 0.64 | EPS this Y | 28.29% | Inst Trans | -9.18% | Short Ratio | 6.18 | Perf Half Y | -7.57% |
| Sales | 0.12B | P/B | 0.79 | EPS next 5Y | 24.51% | ROA | -27.97% | Short Interest | 0.93M | Perf YTD | 8.63% |
| Book/sh | 5.13 | P/C | 0.51 | EPS past 3/5Y | 52.71% 28.06% | ROE | -59.17% | 52W High | -69.9% ($13.39) | Perf Year | -68.09% |
| Cash/sh | 7.84 | P/FCF | - | Sales past 3/5Y | 1.17% 19.06% | ROIC | -37.48% | 52W Low | 41.88% ($2.84) | Perf 3Y | -91.25% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 79.82% | Gross Margin | 41.76% | Volatility(W/M) | 6.3% 7.36% | Perf 5Y | -99.5% |
| Dividend TTM | - | EV/Sales | 0.28 | Sales Y/Y TTM | -1.26% | Oper. Margin | -55.82% | ATR (14) | 0.28 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 4.11 | EPS Q/Q | 7.57% | Profit Margin | -63.06% | RSI (14) | 51.79 | Recom | 1.67 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.19 | Sales Q/Q | 0.69% | SMA20 | -1.52% ($4.09) | Beta | 1.99 | Target Price | $7.67 |
| Payout | - | Debt/Eq | 1.08 | Earnings | 2026/11/4 | SMA50 | 8.1% ($3.73) | Rel Volume | 0.54 | Prev Close | $4.19 |
| Employees | 310 | LT Debt/Eq | 1.06 | EPS/Sales Surpr. | -11.62% 9.21% | SMA200 | -2.92% ($4.15) | Avg Volume(3M) | 0.15M | Price | $4.03 |
| IPO | 2020/9/15 | Option/Short | Yes/Yes | Trades | 1010 | Volume | 81,505 | Change | -3.82% |
🩺 A U.S. medical device company that develops and supplies the touchscreen-based hemodialysis system "Tablo." Founded in 2003 and headquartered in the United States, the company offers dialysis equipment and consumables usable in both hospital and home settings, along with subscription-based software and services.
Over the past 1 year, on the lower side
70% below its 1-year high.
Traded less than usual. That is 54% of its average volume.
Next earnings report: November 4
2 days to go.
OM has a sound balance sheet but weak earning power
Of every $100 in sales, $55.82 is lost.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +28.3% this year.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $64. Peers typically go for $143.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -99.5%. The S&P 500 did +65% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership looks stable
Institutions hold 75.2%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
GLX Corgi GLXY 2x Daily ETF <0.01% 
COPX Global X Copper Miners ETF <0.01% 
HONG Leverage Shares 2X Long HON Daily ETF <0.01% 
FMED Fidelity Disruptive Medicine ETF <0.01% 
LYTE Roundhill Photonics & Optics ETF <0.01% Special products that amplify (leveraged) or invert this single stock. They decay quickly and are not for long-term holding.
BND Vanguard Total Bond Market ETF 166.7B 
AGG iShares Core U.S. Aggregate Bond ETF 139.5B 
GLD SPDR Gold Shares 134.7B 
SGOV iShares 0-3 Month Treasury Bond ETF 116.8B 
BNDX Vanguard Total International Bond ETF 84.7B It ranks #90 of 142 in the industry
Based on market cap of $76M.
SERA#88 Sera Prognostics Inc $80M PER - 
HYPR#89 Hyperfine Inc $76M PER - OM#90 Outset Medical Inc $76M PER - 
MBOT#91 Microbot Medical Inc $73M PER - 
LNSR#92 LENSAR Inc $72M PER - 
FAQ
What kind of company is OM?
OM belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of OM?
The market cap of OM is approximately $76M, ranking 4,628 within its sector.
What is the 52-week high and low for OM?
OM has recorded a 52-week high of $13.39 and a low of $2.84.
